Clinical Trial Update: A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating BEY1107 in combination with temozolomide for recurrent or progressive glioblastoma multiforme; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• BEY1107
• Temozolomide (Temozolomide)

Snippet

Sponsor: BeyondBio Inc. | Conditions: Glioblastoma Multiforme | Phase 1 | Status: RECRUITING